Pancreatic Cancer Research

ResearcherVA Greater Los Angeles Healthcare SystemActive in the last 2 years

Anna S. Gukovskaya

Matched on ORCID iD 0000-0003-3737-5335; OpenAlex author ID A5018920137; NIH RePORTER profile ID 6713448. Sources: OpenAlex.

Their work

Papers
9 (first author 1, last author 4)
Trials
0
Grants
4
Labs led
1
Collaborators
31
Papers, trials and grants by year

2011: 2 papers · 2012: 3 papers · 2013: 2 papers · 2014: none · 2015: none · 2016: 1 grant · 2017: 2 papers · 2018: none · 2019: none · 2020: none · 2021: 1 grant · 2022: none · 2023: none · 2024: 1 grant · 2025: none · 2026: 1 grant

Papers 9

  1. Roles of autophagy and metabolism in pancreatic cancer cell adaptation to environmental challenges. Last author DOI 10.1152/ajpgi.00138.2017↗
  2. Incidence of pancreatic cancer is dramatically increased by a high fat, high calorie diet in KrasG12D mice. Co-author DOI 10.1371/journal.pone.0184455↗
  3. Inflammation, autophagy, and obesity: common features in the pathogenesis of pancreatitis and pancreatic cancer. Co-author DOI 10.1053/j.gastro.2013.02.007↗
  4. NADPH oxidase activation in pancreatic cancer cells is mediated through Akt-dependent up-regulation of p22phox. Last author DOI 10.1074/jbc.a110.200063↗
  5. The burning question: why is smoking a risk factor for pancreatic cancer? Co-author DOI 10.1016/j.pan.2012.06.002↗
  6. The phosphatase PHLPP1 regulates Akt2, promotes pancreatic cancer cell death, and inhibits tumor formation. Last author DOI 10.1053/j.gastro.2011.10.026↗
  7. Epidemiology, risk factors, and the promotion of pancreatic cancer: role of the stellate cell. First author DOI 10.1111/j.1440-1746.2011.07013.x↗
  8. Baicalein, a component of Scutellaria baicalensis, induces apoptosis by Mcl-1 down-regulation in human pancreatic cancer cells. Co-author DOI 10.1016/j.bbamcr.2011.05.003↗
  9. NADPH oxidase activation in pancreatic cancer cells is mediated through Akt-dependent up-regulation of p22phox. Last author DOI 10.1074/jbc.m110.200063↗

Grants 4

  1. BLRD Research Career Scientist Award Application IK6BX005793↗
  2. Cholesterol-lowering drugs for treatment of pancreatitis: validation of a clinically significant novel therapeutic target and approach I21BX006151↗
  3. Cell Death and Autophagy in Chronic Pancreatitis I01BX004306↗
  4. Animal Core P01CA163200↗

Closest collaborators

The 25 strongest of 31 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Stephen Jacob Pandol · 5 shared papers, 1 shared grant, 2011–2017 · strength 0.36
  2. Guido Eibl · 4 shared papers, 1 shared grant, 2011–2017 · strength 0.29
  3. Vay Liang W. Go · 2 shared papers, 1 shared grant, 2011–2017 · strength 0.23
  4. Mouad Edderkaoui · 5 shared papers, 2011–2013 · strength 0.18
  5. Juan Enrique Rozengurt · 1 shared grant, 2016 · strength 0.15
  6. Ilya Gukovsky · 3 shared papers, 2011–2013 · strength 0.12
  7. Kazuki Takakura · 2 shared papers, 2017 · strength 0.12
  8. Claudia J. Nitsche · 3 shared papers, 2011–2013 · strength 0.10
  9. Julia V. Mayerle · 2 shared papers, 2012–2017 · strength 0.09
  10. Markus M. Lerch · 2 shared papers, 2012–2017 · strength 0.09
  11. Paul J. Grippo · 2 shared papers, 2012–2017 · strength 0.09
  12. Aurelia Lugea · 2 shared papers, 2012–2017 · strength 0.09
  13. David W. Dawson · 2 shared papers, 2012–2017 · strength 0.09
  14. Oscar Joe Hines · 2 shared papers, 2011–2017 · strength 0.08
  15. Sandrina Maertin · 1 shared paper, 2017 · strength 0.06
  16. Hui-Hua Chang · 1 shared paper, 2017 · strength 0.05
  17. James W. Sinnett‐Smith · 1 shared paper, 2017 · strength 0.05
  18. Gang Li · 1 shared paper, 2017 · strength 0.05
  19. Richard T. Waldron · 1 shared paper, 2017 · strength 0.05
  20. Enrique Rozengurt · 1 shared paper, 2017 · strength 0.05
  21. Jelena Todoric · 1 shared paper, 2013 · strength 0.05
  22. Ning Li · 1 shared paper, 2013 · strength 0.05
  23. Michael Karin · 1 shared paper, 2013 · strength 0.05
  24. Minoti Vivek Apte · 1 shared paper, 2012 · strength 0.04
  25. Jeremy S. Wilson · 1 shared paper, 2012 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.